May 11 (Reuters) - Hofseth Biocare ASA HOFBC.OL :
* REG-HOFSETH BIOCARE ASA: TWO-YEAR RESEARCH COLLABORATION
CONTRACT SIGNED WITH STANFORD ON THE USE OF SALMON PROTEIN
HYDROLYSATE PEPTIDES FOR THE TREATMENT OF GI TRACT DISEASES IN
CHILDREN AND ADULTS
* FOCUS OF COLLABORATION IS TO FURTHER ELUCIDATE HOW SPH
REDUCES
OR PREVENTS INTESTINAL INFLAMMATION IN PRECLINICAL MODELS OF NEC
Source text for Eikon: ID:nGNEby18wb
Further company coverage: HOFBC.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))